杜邦完成對萊爾德高性能材料的收購

• 萊爾德高性能材料成為電子與工業事業部電子互連科技業務的一部分
• 這項收購強化了杜邦在快速成長的先進電子應用領域的領先地位，支持高性能運算、人工智慧、5G 通訊、智慧/自動駕駛汽車和物聯網等關鍵產業的大趨勢

(德拉瓦州威爾明頓市，2021 年7 月1 日) -- 杜邦公司(紐約證券交易所代碼：DD) 今天宣布已成功完成對高性能電磁屏蔽和熱管理解決方案領域的全球領導者-- 萊爾德高性能材料公司(Laird Performance Materials)的收購。

“我很高興歡迎萊爾德高性能材料優秀的同事加入杜邦，”杜邦執行董事長兼首席執行官Ed Breen說。“萊爾德高性能材料的加入著實強化了杜邦電子與工業(Electronics & Industrial) 部門，也是促進我們發展成為全球創新領導者和首屈一指的多行業公司戰略又一個重要步驟。我對公司邁入新的篇章感到興奮，因為我們將繼續推動高獲利市場的成長，為股東創造長期價值。

正如之前宣布的，萊爾德高性能材料公司 2020 年的收入為 4.65 億美元，全球員工人數約為 4,300 名，將整合到杜邦電子與工業的電子互連科技(Interconnect Solutions) 業務中。萊爾德高性能材料的電磁屏蔽和熱管理產品與電子互連科技在軟板、乾膜、特種薄膜和電鍍化學品方面的產品組合相輔相成。

 “透過結合應用材料科學專業知識與應用工程能力，此次收購使杜邦成為主要電子原始設備製造商(OEM) 的重要合作夥伴，”杜邦電子與工業事業部總裁 Jon Kemp表示。“合併後的組織將共同提升我們在加速採用高性能運算、人工智慧、5G 通訊、智慧/自動駕駛汽車和物聯網方面的領導地位。它同時擴展了我們在整個電子產業鏈中的產品和解決方案組合，並建立我們在關鍵技術的專業知識，這是實現下一代電子設備和基礎設施的關鍵。”

隨著萊爾德高性能材料的加入，杜邦有能力利用擴大的客戶群和全球規模以加快產品上市速度，在開發整合和多功能解決方案中創造新的效率，提供高價值的下一代產品，以在未來幾年實現更高的成長。隨著合併後的電子與工業事業部積極參與跨產業鏈，以解決領先OEM廠商面臨在熱管理、信號完整性、小型化、電源管理和可靠性方面日益複雜的挑戰，我們相信客戶將即刻從中獲益。

杜邦將於即將舉行的第二季度財報電話會議上進一步討論這項交易。

關於杜邦

杜邦公司(紐約證交所代碼:DD) 是全球創新的領導者，提供以科技為基礎的材料和解決方案，為各行各業和人們的日常生活帶來改變。我們的員工運用多樣化的科學技術與專業知識，幫助客戶在電子、交通、建築、水處理、健康與保健和工作防護等關鍵市場，推進最佳創意並提供必要的創新。如需進一步了解有關杜邦公司及其業務和解決方案的資訊，請造訪www.dupont.com 。投資人請瀏覽investors.dupont.com以取得投資者關係相關資訊。

###

7/1/21

杜邦™，杜邦橢圓形標誌和所有標示 ™, ℠ 或 ® 的產品，除非另有說明，均為杜邦公司及其關聯機構的商標，服務標誌或註冊商標。

新聞聯絡人，敬請聯繫：

杜邦公司

Rita  Cheung

電話：+852 2734 5306

信箱：Rita-K.Y.Cheung@dupont.com

Cautionary Statement Regarding Forward Looking Statements

This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," and similar expressions and variations or negatives of these words.

On April 1, 2019, the Company completed the separation of the materials science business through the spin-off of Dow Inc., (“Dow”) including Dow’s subsidiary The Dow Chemical Company (the “Dow Distribution”). On June 1, 2019, the Company completed the separation of the agriculture business through the spin-off of Corteva, Inc. (“Corteva”) including Corteva’s subsidiary E. I. du Pont de Nemours and Company (“EID”), (the “Corteva Distribution and together with the Dow Distribution, the “DWDP Distributions”).

On February 1, 2021, the Company completed the divestiture of the Nutrition & Biosciences (“N&B”) business to International Flavors & Fragrance Inc. (“IFF”) in a Reverse Morris Trust transaction (the “N&B Transaction”) that resulted in IFF issuing shares to DuPont stockholders.

On July 1, 2021, DuPont completed the previously announced acquisition of the Laird Performance Materials business, (the “Laird PM Acquisition”).

Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the ability to achieve expected benefits, synergies and operating efficiencies in connection with the Laird PM Acquisition within the expected time frames or at all or to successfully integrate the Laird Performance Materials business; (ii) ability to achieve anticipated tax treatments in connection with the N&B Transaction, Laird PM Acquisition or the DWDP Distributions; (iii) changes in relevant tax and other laws; (iv) indemnification of certain legacy liabilities of EID in connection with the Corteva Distribution;  (v) risks and costs related to the performance under and impact of the cost sharing arrangement by and between DuPont, Corteva and The Chemours Company related to future eligible PFAS costs; (vi) failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes, including  meeting conditions under the Letter Agreement entered in connection with the Corteva Distribution, related to the transfer of certain levels of assets and businesses; (vii) uncertainty as to the long-term value of DuPont common stock; (viii) risks and uncertainties related to the novel coronavirus (COVID-19) and the responses thereto (such as voluntary and in some cases, mandatory quarantines as well as shut downs and other restrictions on travel and commercial, social and other activities) on DuPont’s business, results of operations, access to sources of liquidity and financial condition which depend on highly uncertain and unpredictable future developments, including, but not limited to, the duration and spread of the COVID-19 outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions resume; and (ix) other risks to DuPont's business, operations; each as further discussed in detail in and results of operations as discussed in DuPont’s annual report on Form 10-K for the year ended December 31, 2020 and its subsequent reports on Form 10-Q and Form 8-K. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.